Axcelis Technologies (ACLS)
(Delayed Data from NSDQ)
$101.29 USD
-0.94 (-0.92%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $101.35 +0.06 (0.06%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ACLS 101.29 -0.94(-0.92%)
Will ACLS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ACLS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACLS
Axcelis Technologies (ACLS) Stock Sinks As Market Gains: What You Should Know
Axcelis Stock Plunges 16% YTD: Should You Buy, Hold or Sell?
ACLS: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for August 29th
Implied Volatility Surging for Axcelis (ACLS) Stock Options
New Strong Sell Stocks for August 13th
Other News for ACLS
Axcelis Technologies Inc (ACLS) Shares Down 5.01% on Sep 16
Axcelis Technologies Inc (ACLS) Trading 3.55% Higher on Sep 13
Warning: ACLS is at high risk of performing badly
Axcelis Announces Sponsorship and Participation in The International Conference on Ion Implantation Technology 2024 in Toyoma, Japan
It's Still Not The Time To Buy Axcelis Technologies